This targeted TRAIL-ATNC (TRAIL-ATNCIL4rP) showed enhanced affinity, stability, and excellent apoptotic activity in vitro, as well as tumor targeting and enhanced anti-tumor efficacy in animal tumor model. This evidence concerns the gene TNFSF10 and neoplasm.